Merck pill hope to prevent deaths from COVID, that's what it costs.

Companies have indicated that they will apply as soon as possible emergency authorisation by the Administration of Bars and Foods (FDA), adding that they had stopped recruiting for their study early because the results were very positive, Reuters writes, translate Periscopi.

Companies said they would also request authorization from regulators around the world.

If they get their authorization, their drug, the shutter, will be the first antivirus drug on the market designed specifically for treating COVID-19 patients.

And recently according to Reuters, the company has a contract with the US government to supply 1.7 million treatments to the country at a price of $700 per cure.

Whether this price will be the same in other countries is still unknown. /PERISCOP/